Delivery Order SPE2DR25D1103-SPE2DR26FE359
Award Date 12/15/25
Potential Completion Date 12/16/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $61,350.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) with an ultimate completion date of December 17, 2025. This non-set-aside, competitively awarded contract represents a single delivery order fulfilling pharmaceutical supply needs within the federal medical procurement system. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded a $57,586.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units), with an ultimate completion date of September 16, 2025. This non-set-aside contract represents a competitive award issued to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $10,854.26 to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count unit of use packaging) on December 9, 2025, with completion expected by December 10, 2025. This firm fixed-price delivery order is non-competitive and represents a single transaction under the company's existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $10,186.03 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30 count) on October 27, 2025, with completion expected by October 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents pharmaceutical procurement to support federal medical supply needs. The vendor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a $15,045.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on November 5, 2025, with completion expected by November 6, 2025. This non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a $19,152.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count unit of use packaging). The contract was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $6,004.97 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit of use packaging) on October 20, 2025, with completion scheduled for October 21, 2025. This non-set-aside award represents a standard pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and...
- The Defense Logistics Agency awarded a $12,446.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement fulfilling federal medical supply requirements. The award was made to AmerisourceBergen's Corporate Office division, located in Conshohocken, Pennsylvania, which serves as the company's primary...
- The Defense Logistics Agency awarded a delivery order valued at $10,040.64 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) with a firm fixed price structure. This non-set-aside competitive award was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. The contract is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a $73,325.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) with a completion date of June 2, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime...